Drug Delivery
Source: Abbott
Soliqs is the drug delivery business of ABBOTT GmbH & Co KG, focusing on the formulation of compounds with poor oral bioavailability, especially when caused by low water solubility or polymorphism.
Soliqs is the drug delivery business of ABBOTT GmbH & Co KG, focusing on the formulation of compounds with poor oral bioavailability, especially when caused by low water solubility or polymorphism.
SOLIQS is a leader in drug delivery with marketed products and a proven track record in enhancing the bioavailability of poorly soluble compounds using its platform technologies Meltrex, Xellex, NanoMorph, SoliScreen and now smartCrystal.
SOLIQS will take all efforts to provide customized solutions and give you consultative support to your situation.
- Meltrex®: Melt Extrusion
- Xellex®: Polymeric Films for Drug Delivery
- NanoMorph®: Colloidal Drug Delivery System
- SoilScreen®: Analytical Tools and Services
- SmartCrystal®: Next generation Crystalline Nanotechnology.